艾艾精工(603580.SH)業績預吿更正:預計2023年淨利潤200萬到300萬元
格隆匯4月21日丨艾艾精工(603580.SH)公佈,公司於2024年1月31日披露了《2023年年度業績預盈公吿》,經公司初步測算,預計2023年年度實現歸屬於上市公司股東的淨利潤為550萬元到800萬元,與上年相比,將實現扭虧為盈。預計2023年年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為234萬元至484萬元。
經公司與年審會計師深入溝通並再次測算,預計2023年年度實現歸屬於上市公司股東的淨利潤為200萬元到300萬元,與上年相比,將實現扭虧為盈。預計2023年年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為130萬元至230萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.